Relation between Skin Cancer and HLA Antigens in Renal-Transplant Recipients

Abstract
Recipients of renal allografts are at an increased risk for skin cancer. It Is also known that recipients who are homozygous for HLA antigens are at an increased risk for certain cancers, as are those who are mismatched with their donors for these antigens. In a case–control study we assessed the relation between skin cancer in renal-transplant recipients and HLA homozygosity and mismatching.